http://health.momentumcuba.com/wp-content/uploads/2017/07/PILOT-STUDY-COMBINE.pdf
Pilot study of a novel combination of two therapeutic vaccines in advanced non‑small‑cell lung cancer patients
by hamit | Jun 21, 2017 | medical-articles |
Recent Posts
- CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer
- Immunotherapy and lung cancer: current developments and novel targeted therapies
- CiMAvax-eGF: A New Therapeutic vaccine for Advanced Non-Small Cell Lung Cancer Patients
- Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients
- “Why an American went to Cuba for cancer care”
Recent Comments